Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) Trial: a global phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose-titration strategy - Hoppe, CC; Styles, L; Heath, LE (Pediatr Blood Cancer, 2016)
et al.